Regencell Bioscience (RGC) vs 22nd Century Group (XXII)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Regencell Bioscience is the larger company by market cap ($3.64 billion vs $579,477), about 6289.7 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | RGC | XXII |
|---|---|---|
| Share price | $7.35 | $0.8116 |
| Market cap | $3.64B | $579.48K |
| 1-day change | -3.67% | -6.79% |
| YTD return | -65.00% | — |
| 1-year return | -60.14% | — |
| 5-year return | +1398.47% | — |
| P/E ratio (TTM) | — | 0.01 |
| EPS (TTM) | $-0.02 | $78.07 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Net income (latest FY) | $-11.70M | — |
| 52-week high | $69.00 | $540.00 |
| 52-week low | $4.51 | $0.785 |
| Distance from 52-week high | -89.35% | -99.85% |
| Average volume | 199.19K | 98.47K |
| Shares outstanding | 495.88M | 713.99K |
| Employees | 10 | 32 |
| Sector | Health Care | Health Care |
| Industry | Medicinal Chemicals and Botanical Products | Medicinal Chemicals and Botanical Products |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Regencell Bioscience is about 6289.7 times larger than 22nd Century Group by market value ($3.64B vs $579.48K).
About Regencell Bioscience
RGC stock →Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder.
Health Care · Medicinal Chemicals and Botanical Products · 10 employees
About 22nd Century Group
XXII stock →22nd Century Group, Inc., a tobacco products company, manufactures, distributes, and sells proprietary new reduced nicotine tobacco products in the United States. The company offers reduced nicotine content tobacco and very low nicotine combustible cigarette products.
Health Care · Medicinal Chemicals and Botanical Products · 32 employees
RGC vs XXII FAQ
Which is bigger, Regencell Bioscience or 22nd Century Group?
Regencell Bioscience (RGC) is larger, with a market capitalization of $3.64B compared with $579.48K for 22nd Century Group (XXII).
Are Regencell Bioscience and 22nd Century Group in the same industry?
Yes. Both are classified in the Medicinal Chemicals and Botanical Products industry within the Health Care sector.